| http://www.w3.org/ns/prov#value | - Combination studies involving 2 synthetic DMARDs, including sulfasalazine and methotrexate, compared with 1 DMARD showed similar withdrawal rates because of adverse events (combination therapy, 10% to 25%; monotherapy, 5.7% to 26.5%) (12???14).
|
